{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:57:39Z","timestamp":1740135459469,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009778","name":"Region J\u00e4mtland H\u00e4rjedalen","doi-asserted-by":"publisher","award":["JLL-474211"],"award-info":[{"award-number":["JLL-474211"]}],"id":[{"id":"10.13039\/501100009778","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12872-019-1030-6","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T08:03:35Z","timestamp":1551686615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9571-5946","authenticated-orcid":false,"given":"Robin","family":"Henriksson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Ulvenstam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"S\u00f6derstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mooe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"issue":"4","key":"1030_CR1","first-page":"354","volume":"119","author":"BJ Witt","year":"2006","unstructured":"Witt BJ, Ballman KV, Brown RD Jr, Meverden RA, Jacobsen SJ, Roger VL. The Incidence of Stroke after Myocardial Infarction: A Meta-Analysis. Am J Med. 2006;119(4):354 e1-.e9.","journal-title":"Am J Med"},{"key":"1030_CR2","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1161\/CIRCULATIONAHA.104.512806","volume":"111","author":"A Budaj","year":"2005","unstructured":"Budaj A, Flasinska K, Gore JM. Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes. Findings from a global registry of acute coronary events. Circulation. 2005;111:3242\u20137.","journal-title":"Circulation"},{"issue":"11","key":"1030_CR3","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/STROKEAHA.113.001434","volume":"44","author":"A Bramm\u00e5s","year":"2013","unstructured":"Bramm\u00e5s A, Jakobsson S, Ulvenstam A, Mooe T. Mortality after ischemic stroke in patients with acute myocardial infarction: predictors and trends over time in Sweden. Stroke. 2013;44(11):3050\u20135.","journal-title":"Stroke."},{"issue":"20","key":"1030_CR4","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","volume":"33","author":"PG Steg","year":"2012","unstructured":"Steg PG, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569\u2013619.","journal-title":"Eur Heart J"},{"issue":"3","key":"1030_CR5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the Management of Acute Coronary Syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267\u2013315.","journal-title":"Eur Heart J"},{"issue":"9","key":"1030_CR6","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","volume":"27","author":"S Husted","year":"2006","unstructured":"Husted S, Emanuelsson H, Heptinstall S, Sandset PM, Wickens M, Peters G. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin. Eur Heart J. 2006;27(9):1038\u201347.","journal-title":"Eur Heart J"},{"issue":"19","key":"1030_CR7","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jacc.2007.07.058","volume":"50","author":"RF Storey","year":"2007","unstructured":"Storey RF, Husted S, Harrington RA, Heptinstall S, Wilcox RG, Peters G, et al. Inhibition of platelet aggregation by AZD6140, a reversible Oral P2Y12 receptor antagonist, compared with Clopidogrel in patients with acute coronary syndromes. J Am Coll Cardiol. 2007;50(19):1852\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1030_CR8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus Clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045\u201357.","journal-title":"N Engl J Med"},{"issue":"20","key":"1030_CR9","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/hrt.2010.198804","volume":"96","author":"T Jernberg","year":"2010","unstructured":"Jernberg T, Attebring MF, Hambraeus K, Ivert T, James S, Jeppsson A, et al. The Swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart. 2010;96(20):1617\u201321.","journal-title":"Heart."},{"issue":"20","key":"1030_CR10","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","volume":"28","author":"K Thygesen","year":"2007","unstructured":"Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. Eur Heart J. 2007;28(20):2525.","journal-title":"Eur Heart J"},{"issue":"1","key":"1030_CR11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Jeong-Lim K, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11(1):450\u201365.","journal-title":"BMC Public Health"},{"issue":"9","key":"1030_CR12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"A Levey","year":"2009","unstructured":"Levey A, Stevens L, Schmid C, Zhang Y, Castro A, Feldman H. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"9711","key":"1030_CR13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(09)62191-7","volume":"375","author":"CP Cannon","year":"2010","unstructured":"Cannon CP, Harrington RA, James S, Ardissino D, Becker RC, Emanuelsson H, et al. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet. 2010;375(9711):283\u201393.","journal-title":"Lancet"},{"issue":"31","key":"1030_CR14","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/eurheartj\/ehu160","volume":"35","author":"D Lindholm","year":"2014","unstructured":"Lindholm D, Varenhorst C, Cannon CP, Harrington RA, Himmelmann A, Maya J, et al. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial. Eur Heart J. 2014;35(31):2083\u201393.","journal-title":"Eur Heart J"},{"issue":"5","key":"1030_CR15","first-page":"680","volume":"5","author":"S Husted","year":"2012","unstructured":"Husted S, James S, Becker RC, Horrow J, Katus H, Storey RF, et al. Ticagrelor versus Clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient outcomes (PLATO) trial. Circulation: Cardiovascular Quality and Outcomes. 2012;5(5):680\u20138.","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"issue":"2","key":"1030_CR16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.atherosclerosis.2014.01.017","volume":"233","author":"X-F Tang","year":"2014","unstructured":"Tang X-F, Fan J-Y, Meng J, Jin C, Yuan J-Q, Yang Y-J. Impact of new oral or intravenous P2Y12 inhibitors and clopidogrel on major ischemic and bleeding events in patients with coronary artery disease: a meta-analysis of randomized trials. Atherosclerosis. 2014;233(2):568\u201378.","journal-title":"Atherosclerosis."},{"issue":"2","key":"1030_CR17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijcard.2014.05.024","volume":"175","author":"N Naderi","year":"2014","unstructured":"Naderi N, Masoomi H, Mozaffar T, Malik S. Patient characteristics and comorbidities associated with cerebrovascular accident following acute myocardial infarction in the United States. Int J Cardiol. 2014;175(2):323\u20137.","journal-title":"Int J Cardiol"},{"key":"1030_CR18","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/archinte.168.19.2104","volume":"168","author":"JS Saczynski","year":"2008","unstructured":"Saczynski JS, Spencer FA, Gore JM. Twenty-year tends in the incidence of stroke complicating acute myocardial infarction. Arch Intern Med. 2008;168:2104\u201310.","journal-title":"Arch Intern Med."},{"issue":"12","key":"1030_CR19","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1161\/STROKEAHA.114.006707","volume":"45","author":"O Hachet","year":"2014","unstructured":"Hachet O, Guenancia C, Stamboul K, Daubail B, Richard C, B\u00e9jot Y, et al. Frequency and predictors of stroke after acute myocardial infarction: specific aspects of in-hospital and Postdischarge events. Stroke. 2014;45(12):3514\u201320.","journal-title":"Stroke."},{"issue":"1","key":"1030_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2261-12-64","volume":"12","author":"J Suwaidi Al","year":"2012","unstructured":"Al Suwaidi J, Al Habib K, Asaad N, Singh R, Hersi A, Al Falaeh H, et al. Immediate and one-year outcome of patients presenting with acute coronary syndrome complicated by stroke: findings from the 2nd gulf registry of acute coronary events (gulf RACE-2). BMC Cardiovasc Disord. 2012;12(1):1\u20139.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"1030_CR21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/CIRCOUTCOMES.113.000311","volume":"7","author":"S Jakobsson","year":"2014","unstructured":"Jakobsson S, Bergstr\u00f6m L, Bj\u00f6rklund F, Jernberg T, S\u00f6derstr\u00f6m L, Mooe T. Risk of ischemic stroke after an acute myocardial infarction in patients with diabetes mellitus. Circ Cardiovasc Qual Outcomes. 2014;7(1):95\u2013101.","journal-title":"Circ Cardiovasc Qual Outcomes."},{"issue":"11","key":"1030_CR22","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1161\/STROKEAHA.114.005770","volume":"45","author":"A Ulvenstam","year":"2014","unstructured":"Ulvenstam A, Kajermo U, Modica A, Jernberg T, Soderstrom L, Mooe T. Incidence, trends, and predictors of ischemic stroke 1 year after an acute myocardial infarction. Stroke. 2014;45(11):3263\u20138.","journal-title":"Stroke."},{"issue":"11","key":"1030_CR23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-143-11-200512060-00006","volume":"143","author":"BJ Witt","year":"2005","unstructured":"Witt BJ, Brown JRD, Jacobsen SJ, Weston SA, Yawn BP, Roger VL. A community-based study of stroke incidence after myocardial infarction. Ann Intern Med. 2005;143(11):785\u201392.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1030_CR24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1586\/14737175.2.2.177","volume":"2","author":"T Mooe","year":"2002","unstructured":"Mooe T. Risk, mechanisms and prevention of stroke after an acute myocardial infarction. Expert Rev Neurother. 2002;2(2):177\u201386.","journal-title":"Expert Rev Neurother"},{"key":"1030_CR25","doi-asserted-by":"publisher","unstructured":"Joshi NV, Toor I, Shah AS, et al. Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction. J Am Heart Assoc. 2015;4(9):e001956. Published 2015 Aug 27. \n                    https:\/\/doi.org\/10.1161\/JAHA.115.001956\n                    \n                  .","DOI":"10.1161\/JAHA.115.001956"},{"issue":"2","key":"1030_CR26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1053\/j.ajkd.2009.04.023","volume":"54","author":"F Karlsson","year":"2009","unstructured":"Karlsson F, Modica A, Mooe T. Association of Level of kidney function and platelet aggregation in acute myocardial infarction. Am J Kidney Dis. 2009;54(2):262\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1030_CR27","first-page":"390","volume":"37","author":"JA Udell","year":"2016","unstructured":"Udell JA, Bonaca MP, Collet J-P, Lincoff AM, Kereiakes DJ, Costa F, et al. Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials. Eur Heart J. 2016;37(4):390\u20139.","journal-title":"Eur Heart J"},{"issue":"19","key":"1030_CR28","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","volume":"372","author":"MP Bonaca","year":"2015","unstructured":"Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, et al. Long-term use of Ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015;372(19):1791\u2013800.","journal-title":"N Engl J Med"},{"key":"1030_CR29","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.2147\/DDDT.S105718","volume":"10","author":"MR Preusch","year":"2016","unstructured":"Preusch MR, Rusnak J, Staudacher K, Mogler C, Uhlmann L, Sievers P, et al. Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis. Drug Des Devel Ther. 2016;10:2691\u20139.","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"1030_CR30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ijcard.2007.06.018","volume":"128","author":"J Herlitz","year":"2008","unstructured":"Herlitz J, Dellborg M, Karlsson T, Evander MH, Berger A, Luepker R. Epidemiology of acute myocardial infarction with the emphasis on patients who did not reach the coronary care unit and non-AMI admissions. Int J Cardiol. 2008;128(3):342\u20139.","journal-title":"Int J Cardiol"},{"key":"1030_CR31","unstructured":"Jernberg T, Held C, Rydberg E. Swedeheart annual report 2014 - RIKS HIA. Online at \n                    https:\/\/www.ucr.uu.se\/swedeheart\/arsrapport-2017\/aeldre-arsrapporter-older-reports\n                    \n                  ; 2015."}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1030-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-019-1030-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1030-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T19:17:58Z","timestamp":1583176678000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-019-1030-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1030"],"URL":"https:\/\/doi.org\/10.1186\/s12872-019-1030-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2019,3,4]]},"assertion":[{"value":"15 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The RIKS-HIA registry was approved by the National Board of Health and Welfare and the Swedish Data Inspection Board. The Regional ethics committee in Stockholm approved merging of the registries and the requirement for written consent was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RH, AU, LS have nothing to declare. TM has participated in Advisory boards for Astra-Zeneca, Pfizer and Bayer","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"51"}}